# Effect of Tinzaparin on Inflammatory Biomarkers During the Acute Phase of Deep Vein Thrombosis

> **NCT04741464** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Centre Hospitalier Universitaire, Amiens** · enrollment: 9 (actual)

## Conditions studied

- Deep Vein Thrombosis
- Inflammatory Response

## Interventions

- **DRUG:** Tinzaparin

## Key facts

- **NCT ID:** NCT04741464
- **Lead sponsor:** Centre Hospitalier Universitaire, Amiens
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-02-02
- **Primary completion:** 2023-11-22
- **Final completion:** 2025-11
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2025-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04741464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04741464, "Effect of Tinzaparin on Inflammatory Biomarkers During the Acute Phase of Deep Vein Thrombosis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04741464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*